Literature DB >> 12176049

Rolling properties of rGPIbalpha-conjugated phospholipid vesicles with different membrane flexibilities on vWf surface under flow conditions.

Shinji Takeoka1, Yuji Teramura, Yosuke Okamura, Eishun Tsuchida, Makoto Handa, Yasuo Ikeda.   

Abstract

The recombinant fragment of the platelet membrane glycoprotein, rGPIbalpha, was conjugated to phospholipid vesicles with the average diameter of ca. 1 microm using N-succinimidyl 3-(2-pyridyldithio) propionate (SPDP). We used five kinds of rGPIbalpha-vesicles with different fluorescent anisotropies of 1,6-diphenyl-1,3,5-hexatriene (DPH) to study the rolling properties of the vesicles on the von Willebrand factor (vWf)-immobilized surface. Under flow conditions, the rolling velocity of the rGPIbalpha-vesicles decreased with the increasing membrane flexibility. It is considered that the vesicles with a high membrane flexibility have a high deformability and can be flattened to a high degree during rolling on the vWf surface, thus resulting in the large contact area. We obtained a recipe to control the rolling velocity of artificial platelets by membrane flexibility.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12176049     DOI: 10.1016/s0006-291x(02)00934-8

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  12 in total

1.  An assessment of the effects of shell cross-linked nanoparticle size, core composition, and surface PEGylation on in vivo biodistribution.

Authors:  Xiankai Sun; Raffaella Rossin; Jeffrey L Turner; Matthew L Becker; Maisie J Joralemon; Michael J Welch; Karen L Wooley
Journal:  Biomacromolecules       Date:  2005 Sep-Oct       Impact factor: 6.988

2.  New strategy of platelet substitutes for enhancing platelet aggregation at high shear rates: cooperative effects of a mixed system of fibrinogen gamma-chain dodecapeptide- or glycoprotein Ibalpha-conjugated latex beads under flow conditions.

Authors:  Yosuke Okamura; Makoto Handa; Hidenori Suzuki; Yasuo Ikeda; Shinji Takeoka
Journal:  J Artif Organs       Date:  2006-12-21       Impact factor: 1.731

3.  Coarse-grained modeling study of nonpeptide RGD ligand density and PEG molecular weight on the conformation of poly(γ-glutamyl-glutamate) paclitaxel conjugates.

Authors:  Lili X Peng; Sanjib K Das; Lei Yu; Stephen B Howell; David A Gough
Journal:  J Mol Model       Date:  2011-03-01       Impact factor: 1.810

Review 4.  Bio-inspired nanomedicine strategies for artificial blood components.

Authors:  Anirban Sen Gupta
Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol       Date:  2017-03-15

Review 5.  Synthetic Strategies for Engineering Intravenous Hemostats.

Authors:  Leslie W Chan; Nathan J White; Suzie H Pun
Journal:  Bioconjug Chem       Date:  2015-04-06       Impact factor: 4.774

Review 6.  Bioinspired artificial platelets: past, present and future.

Authors:  Norman F Luc; Nathan Rohner; Aditya Girish; Ujjal Didar Singh Sekhon; Matthew D Neal; Anirban Sen Gupta
Journal:  Platelets       Date:  2021-08-30       Impact factor: 3.862

Review 7.  Factors affecting the clearance and biodistribution of polymeric nanoparticles.

Authors:  Frank Alexis; Eric Pridgen; Linda K Molnar; Omid C Farokhzad
Journal:  Mol Pharm       Date:  2008-08-04       Impact factor: 4.939

Review 8.  Non-affinity factors modulating vascular targeting of nano- and microcarriers.

Authors:  Jacob W Myerson; Aaron C Anselmo; Yaling Liu; Samir Mitragotri; David M Eckmann; Vladimir R Muzykantov
Journal:  Adv Drug Deliv Rev       Date:  2015-10-24       Impact factor: 15.470

Review 9.  Biomaterials and Advanced Technologies for Hemostatic Management of Bleeding.

Authors:  DaShawn A Hickman; Christa L Pawlowski; Ujjal D S Sekhon; Joyann Marks; Anirban Sen Gupta
Journal:  Adv Mater       Date:  2017-11-22       Impact factor: 30.849

Review 10.  Bioinspired artificial platelets for transfusion applications in traumatic hemorrhage.

Authors:  Aditya Girish; Ujjal Sekhon; Anirban Sen Gupta
Journal:  Transfusion       Date:  2019-10-18       Impact factor: 3.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.